HILLARY HOUSE: Open Payments
NPI 1982046587 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 31 payments from 12 companies in 2025. Trend: 2023 $449 · 2024 $898 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $131 |
| Supernus Pharmaceuticals, Inc. | 5 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
| Noven Therapeutics, LLC | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Neos Therapeutics, LP | 1 | $22 |
| Corium, LLC | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: Auvelity, Qelbree, HETLIOZ, Xelstrym, AUSTEDO XR, Jornay PM, SPRAVATO, Adzenys XR-ODT.
Industry payments across IN — which companies pay providers there.
